Docosahexaenoic acid prevents neuronal apoptosis induced by soluble amyloid-beta oligomers |
| |
Authors: | Florent Sabrina Malaplate-Armand Catherine Youssef Ihsen Kriem Badreddine Koziel Violette Escanyé Marie-Christine Fifre Alexandre Sponne Isabelle Leininger-Muller Brigitte Olivier Jean-Luc Pillot Thierry Oster Thierry |
| |
Institution: | Jeune Equipe Lipidomix, Institut National Polytechnique de Lorraine, Laboratoire Médecine et Thérapeutique Moléculaire, Vandoeuvre-lès-Nancy, France. |
| |
Abstract: | A growing body of evidence supports the notion that soluble oligomers of amyloid-beta (Abeta) peptide interact with the neuronal plasma membrane, leading to cell injury and inducing death-signalling pathways that could account for the increased neurodegeneration occurring in Alzheimer's disease (AD). Docosahexaenoic acid (DHA, C22:6, n-3) is an essential polyunsaturated fatty acid in the CNS and has been shown in several epidemiological and in vivo studies to have protective effects against AD and cognitive alterations. However, the molecular mechanisms involved remain unknown. We hypothesized that DHA enrichment of plasma membranes could protect neurones from apoptosis induced by soluble Abeta oligomers. DHA pre-treatment was observed to significantly increase neuronal survival upon Abeta treatment by preventing cytoskeleton perturbations, caspase activation and apoptosis, as well as by promoting extracellular signal-related kinase (ERK)-related survival pathways. These data suggest that DHA enrichment probably induces changes in neuronal membrane properties with functional outcomes, thereby increasing protection from soluble Abeta oligomers. Such neuroprotective effects could be of major interest in the prevention of AD and other neurodegenerative diseases. |
| |
Keywords: | Alzheimer's disease docosahexaenoic acid neuronal apoptosis neuroprotection soluble amyloid-β peptide |
本文献已被 PubMed 等数据库收录! |
|